已收盘
0.000
NaN.00%
PXMD: 171% | PaxMedica shares are trading higher after the company announced the completed execution of three pivotal registration/validation batches of PAX-101. NXPL: 98% | NextPlat shares are
2024-04-12 20:43
PaxMedica, Inc. (NASDAQ: PXMD) experienced notable price swings on Thursday, in...
2024-04-12 14:35
Shares of PaxMedica (NASDAQ:PXMD) shot up 125% in post-market trading Thursday after the company announced it had completed execution of three registration/validation batches of its drug PAX-101, an I...
2024-04-12 04:53
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 175 points on Wednesday. The Dow traded up 0.50% to 35,265 while the NASDAQ rose 0.66% to 14,293.93. The S&P 500 also rose, gaining, 0.47% to 4,559.53.
2023-11-23 03:33
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 150 points on Wednesday. The Dow traded up 0.51% to 35,266.35 while the NASDAQ rose 0.59% to 14,284.26. The S&P 500 also rose, gaining, 0.45% to 4,558.48.
2023-11-23 01:00
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 200 points on Monday. The Dow traded up 0.60% to 35,157.62 while the NASDAQ rose 1.09% to 14,279.03. The S&P 500 also rose, gaining, 0.75% to 4,548.10.
2023-11-21 03:37
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining over 100 points on Monday. The Dow traded up 0.34% to 35,064.42 while the NASDAQ rose 0.80% to 14,238.67. The S&P 500 also rose, gaining, 0.43% to 4,534.85.
2023-11-21 01:09
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more than 50 points on Monday. Following the market opening Monday, the Dow traded up 0.12% to 34,988.28 while the NASDAQ rose 0.49% to 14,194.23. The S&P 500 also rose, gaining, 0.17% to 4,521.69.
2023-11-20 22:46
PaxMedica, Inc. (NASDAQ: PXMD) shares are trading higher on Tuesday. The stock has been volatile over the past month.
2023-11-15 04:46
PXMD: 90% | PaxMedica Announces Publication of Its Autism Spectrum Disorder Phase 2 Study Results in Peer-reviewed Journal OLPX: 40% | Olaplex Hldgs Q3 Adj EPS $0.05 Beats $0.04 Estimate, Sales
2023-11-07 21:38